Fiche publication
Date publication
novembre 2024
Journal
The European respiratory journal
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BONNIAUD Philippe
,
Dr BELTRAMO Guillaume
Tous les auteurs :
Yavordios S, Beltramo G, Freppel R, Salinas FB, Le Beller C, Bihan K, Mouillot P, Georges M, Grandvuillemin A, Bonniaud P
Lien Pubmed
Résumé
Drug-induced interstitial lung disease (DI-ILD) is a heterogeneous subgroup of interstitial lung diseases (ILD). The number of molecules involved is increasing with time. Due to their low incidence, DI-ILDs may be detected only after a drug has been marketed, notably through Adverse Drug Reaction (ADR) reports to pharmacovigilance centres. The aim of our study was to describe drug-induced diffuse lung disease cases notified to and recorded by the French Pharmacovigilance Database (FPVD), reported clinical pictures and the potentially causal drugs.
Référence
Eur Respir J. 2024 11 7;:
